Bone Metabolism Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: June 13, 2024 Report Code: GDME1758EPD-ST

Select Item

Bone Metabolism Assays Pipeline Market Report Overview

Bone Metabolism Assays include laboratory tests that examine the mineral composition of the bones and the parameters of bone formation and resorption. The Bone Metabolism Assays pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       Europe

·       Global

·       United States

·       China
Key Segments ·       25-OH Vitamin D Tests

·       Parathyroid Hormone (PTH) Tests

·       Calcitonin Tests
Key Regulatory Paths ·       510(k)

·       CE-IVD

·       NMPA
Leading Companies ·       AMS Diagnostics LLC

·       Axis-Shield Diagnostics Ltd

·       Carolina Liquid Chemistries Corp

·       DiaSorin SpA

·       Guangzhou Wondfo Biotech Co Ltd
Enquire & Decide Discover the perfect solution for your business needs. Enquire nows and let us help you make an informed decision before making a purchase.

Bone Metabolism Assays Pipeline Market Segmentation by Territories

A few of the key territories for Bone Metabolism Assays pipeline products are the US, Europe, Global, and China. As of June 2024, the US, Europe, and Global segments have an equal number number of Bone Metabolism Assays pipeline products.

Bone Metabolism Assays Pipeline Market Analysis by Territories, 2024 (%)

Bone Metabolism Assays Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Bone Metabolism Assays Pipeline Market

Download a Free Report Sample

Bone Metabolism Assays Pipeline Market – Key Segments

A few of the key segments in the Bone Metabolism Assays pipeline market are 25-OH Vitamin D Tests, Parathyroid Hormone (PTH) Tests, and Calcitonin Tests. As of June 2024, 25-OH Vitamin D Tests have the highest number of pipeline products.

Bone Metabolism Assays Pipeline Market Analysis by Segments, 2024 (%)

Bone Metabolism Assays Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Bone Metabolism Assays Pipeline Market

Download a Free Report Sample

Bone Metabolism Assays Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Bone Metabolism Assays pipeline market are 510(k), CE-IVD, and NMPA. As of June 2024, 510(K) and CE-IVD are the most followed pathways for pipeline products in the market.

Bone Metabolism Assays Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Bone Metabolism Assays Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Bone Metabolism Assays Pipeline Market

Download a Free Report Sample

Bone Metabolism Assays Pipeline Market – Competitive Landscape

A few of the key companies associated with the Bone Metabolism Assays pipeline market are AMS Diagnostics LLC, Axis-Shield Diagnostics Ltd, Carolina Liquid Chemistries Corp, DiaSorin SpA, and Guangzhou Wondfo Biotech Co Ltd among others.

Carolina Liquid Chemistries Corp (CCLC): CLCC is a medical device company that manufactures and markets chemistry instruments and reagents. The company provides products such as drug testing devices, chemistry analyzers, chemistry reagents, refurbished chemistry analyzers, and others. Its chemistry analyzers find applications in various testing purposes which include general chemistry tests, urine drug tests, adulterant tests, and others. CLCC also provides maintenance and support services. The company serves clinical chemistry laboratories, hospitals, clinical reference laboratories, and physician practices, among others. It has operations in California and North Carolina. CLCC is headquartered in Greensboro, North Carolina, the US.

Bone Metabolism Assays Pipeline Market Analysis by Companies, 2024

Bone Metabolism Assays Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Bone Metabolism Assays Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Bone Metabolism Assays Pipeline Market Territories Outlook

  • United States
  • Europe
  • Global
  • China

Bone Metabolism Assays Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE-IVD
  • NMPA

Scope

This report provides:

  • Extensive coverage of the Bone Metabolism Assays under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of Bone Metabolism Assays and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Bone Metabolism Assays under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AMS Diagnostics LLC
Axis-Shield Diagnostics Ltd
Carolina Liquid Chemistries Corp
DiaSorin SpA
Guangzhou Wondfo Biotech Co Ltd
Roche Diagnostics Corp
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Siemens Healthcare Diagnostics Inc
Tosoh Bioscience Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Bone Metabolism Assays Overview

  • 3 Products under Development

    • 3.1 Bone Metabolism Assays – Pipeline Products by Stage of Development

    • 3.2 Bone Metabolism Assays – Pipeline Products by Segment

    • 3.3 Bone Metabolism Assays – Pipeline Products by Territory

    • 3.4 Bone Metabolism Assays – Pipeline Products by Regulatory Path

    • 3.5 Bone Metabolism Assays – Pipeline Products by Estimated Approval Date

  • 4 Bone Metabolism Assays – Pipeline Products under Development by Companies

    • 4.1 Bone Metabolism Assays Companies – Pipeline Products by Stage of Development

    • 4.2 Bone Metabolism Assays – Pipeline Products by Stage of Development

  • 5 Bone Metabolism Assays Companies and Product Overview

    • 5.1 AMS Diagnostics LLC Company Overview

      • 5.1.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Axis-Shield Diagnostics Ltd Company Overview

      • 5.2.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Carolina Liquid Chemistries Corp Company Overview

      • 5.3.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 DiaSorin SpA Company Overview

      • 5.4.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Guangzhou Wondfo Biotech Co Ltd Company Overview

      • 5.5.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Roche Diagnostics Corp Company Overview

      • 5.6.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview

      • 5.7.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Siemens Healthcare Diagnostics Inc Company Overview

      • 5.8.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Tosoh Bioscience Inc Company Overview

      • 5.9.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Bone Metabolism Assays- Recent Developments

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Bone Metabolism Assays – Pipeline Products by Stage of Development 7

Bone Metabolism Assays – Pipeline Products by Segment 8

Bone Metabolism Assays – Pipeline Products by Territory 9

Bone Metabolism Assays – Pipeline Products by Regulatory Path 10

Bone Metabolism Assays – Pipeline Products by Estimated Approval Date 11

Bone Metabolism Assays Companies – Pipeline Products by Stage of Development 12

Bone Metabolism Assays – Pipeline Products by Stage of Development 13

AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 14

Liasys 450 – Vitamin D Assay – Product Status 14

Liasys 450 – Vitamin D Assay – Product Description 14

Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 15

Vitamin D Assay – Product Status 15

Vitamin D Assay – Product Description 15

Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 16

CLC 480 Analyzer – Vitamin D Assay – Product Status 16

CLC 480 Analyzer – Vitamin D Assay – Product Description 16

DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 17

LIAISON – Hyperphosphate High Bone Turnover Assay – Product Status 17

LIAISON – Hyperphosphate High Bone Turnover Assay – Product Description 17

LIAISON – Hyperphosphate Low Bone Turnover Assay – Product Status 18

LIAISON – Hyperphosphate Low Bone Turnover Assay – Product Description 18

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Accre Diagnostic Assay – PTH – Product Status 19

Accre Diagnostic Assay – PTH – Product Description 19

Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 20

Cobas i601 – 24,25OH2 Vit D2 Assay – Product Status 20

Cobas i601 – 24,25OH2 Vit D2 Assay – Product Description 20

Cobas i601 – 24,25OH2 Vit D3 Assay – Product Status 21

Cobas i601 – 24,25OH2 Vit D3 Assay – Product Description 21

Cobas i601 – 25OH Vit D2 Assay – Product Status 21

Cobas i601 – 25OH Vit D2 Assay – Product Description 22

Cobas i601 – 25OH Vit D3 Assay – Product Status 22

Cobas i601 – 25OH Vit D3 Assay – Product Description 22

Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

CL-1000i – Calcitonin Test – Product Status 23

CL-1000i – Calcitonin Test – Product Description 23

CL-1000i – Intact PTH Test – Product Status 24

CL-1000i – Intact PTH Test – Product Description 24

CL-1000i – Vitamin D Total Test – Product Status 24

CL-1000i – Vitamin D Total Test – Product Description 25

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Dimension Vista 1500 Intelligent Lab System – Loci Vitamin D Assay – Product Status 26

Dimension Vista 1500 Intelligent Lab System – Loci Vitamin D Assay – Product Description 26

Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 27

AIA-360 – Vitamin D Test – Product Status 27

AIA-360 – Vitamin D Test – Product Description 27

Glossary 33

Figures

Bone Metabolism Assays – Pipeline Products by Stage of Development 7

Bone Metabolism Assays – Pipeline Products by Segment 8

Bone Metabolism Assays – Pipeline Products by Territory 9

Bone Metabolism Assays – Pipeline Products by Regulatory Path 10

Bone Metabolism Assays – Pipeline Products by Estimated Approval Date 11

Frequently asked questions

Bone Metabolism Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Bone Metabolism Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Bone Metabolism Assays reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bone Metabolism Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Bone Metabolism Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more